Nip+Fab Retinol Fix Blemish Treatment Gel 10% 15ml

This revolutionary spot treatment gel has a 10% time-release retinol complex with 0.1% Lipodisq encapsulated pure retinol to deeply penetrate skin overnight and target blemishes, dark spots and pore size, by accelerating cell turnover to help repair skin faster. Formulated with salicylic acid and tranexamic acid to help improve the appearance of active blemishes, fade dark spots for an overall more even toned complexion, as well as niacinamide to help reduce the appearance of pores. The lightweight texture is gentle enough to use twice daily without leaving a residue.Clinically proven to reduce the appearance of skin blemishes in four weeks*After 24 hours*93% agree skin looks visibly clearer93% agree blemishes have been improved87% agree it's the fastest acting blemish treatment they have usedAfter 4 weeks*90% agree blemishes have been completely healed96% agree it's the best blemish product they have ever used100% agree skin looks less congested96% agree any remaining scarring from previous blemishes appears reducedWhy use encapsulated retinol?This formula contains a slow-release complex with encapsulated pure retinol, which converts to retinoic acid (the most active form of retinol) quicker and is less irritating than other forms. We use three encapsulation techniques to ensure the range is suitable for everyone, for layering in a routine and to minimise the chance of irritation. Fragrance Free | Vegan | Cruelty FreeHow it works:10% time-release retinol complex, including 0.1% encapsulated pure retinol in a biodegradable, water-loving structure for a controlled, deeper release2% Niacinamide helps to even skin tone and diminish pore size2% Trivalin Sf helps to strengthen the skin's structure0.6% Butylene Glycol known to hydrate by drawing moisture to the skin0.5% Tranexamic acid acts as a brightening agent to reduce dark spots and improve skin texture0.5% Salicylic acid helps to purify and exfoliate, improving blemishes and the look of pores​*Based on a clinical trial of 31 participants for 4 weeks, daily in the evening (PM) only